No Detail Found!

Dynamic changes and clinical significance of serum S100B protein and glial fibrillary acidic protein in patients with delayed encephalopathy after acute carbon monoxide poisoning.

Author(s)
Chong Di Emergency Center, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China
Yun Zeng Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing 210009, Jiangsu Province, China
Jingyu Mao Jiangsu Collaborative Innovation Center of Traditional Chines Medicine (TCM). Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu Province, China.
Zhengjie Shen Medical Oncology of Zhangjiagang First People’s Hospital, Zhangjiagang 215600, Jiangsu Province, China
Wenzhe Gu Depr. of Otorhinolaryngology, Zhangjiagang Hospital of Traditional Chinese Medicine, Zhangjiagang 215600, Jiangsu Province, China
Abstract
Objective: To study the dynamic changes and clinical significance of serum S100B protein and glial fibrillary acidic protein (GFAP) in patients with delayed encephalopathy after acute carbon monoxide poisoning (DEACMP). Methods: This study was conducted among DEACMP patients who were hospitalized from November 2014 to February 2016. Serum levels of S100B and GFAP in 66 DEACMP patients were measured by ELISA. Changes in patient states were examined dynamically using activities of daily living (ADL) scale, information-memoryconcentration test (IMCT) and Hasegawa's dementia scale (HDS), and compared with those of 64 patients without DE after ACMP. Results: Serum S100B [(0.59 ± 0.11) ng/ml] and GFAP [(227.67 ± 12.43) ng/ml] levels of DEACMP group in acute phase were significantly higher than those of ACMP group [(0.48 ± 0.10) ng/ml and (178.91 ± 11.47) ng/ml] and DEACMP group in recovery phase [(0.49 ± 0.12) ng/ml and (179.54 ± 12.32) ng/ml] (all P<0.05). Serum S100B and GFAP levels of DEACMP group were significantly correlated in both acute and recovery phases (r=0.432 in acute phase, P=0.007; r=0.378 in recovery phase, P=0.034). ADL, HDS and IMCT scores of DEACMP group in acute phase were (45.12 ± 3.12), (7.98 ± 1.02) and (9.61 ± 1.41) points respectively, which were significantly different from those of recovery phase [(33.25 ± 3.09), (16.13 ± 1.17) and (19.54 ± 1.43) points respectively] (P<0.05). Conclusions: DEACMP was accompanied by secondary brain injury, for which glial activation may be important. Serum S100B and GFAP levels may be related to prognosis.
Publication Details
Page(s) 945-949
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 34, Issue: 4, Year: 2018

Request the full text from PASTIC

Keywords
Glial bfirillary acidic protein
0

Citations

0

Downloads

60

Views